Industry Overview

Drug of abuse is illegal drugs which are taken for the non-medical purpose. Testing of drugs of abuse is done with the help of samples of urine, hair, saliva, etc. The global at-home drug of abuse market is growing at a significant rate, due to the mounting usage of illegal drugs among teenagers, and augmented manufacture and exchange of illicit drugs.

The different products such as rapid drug of abuse test kits and breath analyzers contributed to the at-home drug of abuse market size. The market has witnessed a high demand for rapid drug of abuse test kits due to an upsurge in acceptance of several types of rapid DOA test kits and the existence of a huge number of manufacturing players.

Market Segmentation

Insight by Product

On the basis of product, the market is subdivided into rapid drug of abuse test kits and breath analyzers. Of all products, rapid drug of abuse test kits segment accounted the larger share and is expected to grow at faster rate in the market, due to an upsurge in acceptance of several types of rapid drug of abuse test kits, cost-effective, and the existence of a huge number of manufacturing players.

The rapid drug of abuse test kits is further subdivided into test dip cards, test cups, test strips, and others. Among all the test cups segment accounted for the largest share in the market, due to the widespread usage of test cups for urine testing at home.

Insight by Sample

On the basis of the sample, the market is subdivided into urine, hair, saliva, and others. Of all the samples, the urine accounted foremost share and is expected to grow at the fastest rate in the at-home drug of abuse market, as it is easy to use and cost effective.

Global At-Home Drug of Abuse Market Report Coverage

Report Metric	Details
Historical Period	2020 - 2024
Base Year Considered	2025
Forecast Period	2026 - 2035
Market Size in 2025	U.S.D.  xx.x Billion
Revenue Forecast in 2035	U.S.D.  xx.x Billion
Growth Rate	x.x%
Segments Covered in the Report	By Product and By Sample
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

Mounting dependence for synthetic cannabinoids, bath salts, and other evolving drugs are the trends in the at-home drug of abuse market. For instance, synthetic cannabinoids are structurally analogous to phytocannabinoids. It is human-made chemicals which are sprayed on dried plant material. It is similar to chemicals found in the marijuana plant. Moreover, bath salt is a human-made stimulant related to cathinone. Some of the health effects of synthetic cathinones are raised heart rate, chest pain and raised blood pressure.

Growth Drivers

Augmented manufacture and exchange of illegal drugs, technological advancement, programs by government organizations to decrease the intensity of drug abuse, and mounting usage of illicit drugs among teenagers are the primary growth drivers for an at-home drug of abuse market. For instance, according to the World Health Organization, globally in 2013, approximately 181.8 million people aged 15 to 64 years used cannabis for nonmedical purposes.

Moreover, the overdose of opioids leads to unfavorable and severe health conditions. For instance, according to the National Institute on Drug Abuse, in 2016, approximately, 2.14 million people aged 12 years and older had an opioid use disorder.

Mounting alertness about DOA testing, amplified usage of the drug of abuse tests for lawful and medical purposes, and alternative substance addiction are also facilitating the growth for the at-home drug of abuse market.

Challenges

Certification of illicit drugs, the incompetence of testing products to identify exclusive drugs, and social issues related to substance usage testing are the major challenges for the growth of at-home drug of abuse market.

Industry Ecosystem

Globally, the manufacturing companies trying to enter the at-home drug of abuse market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.

Geographic Overview

Geographically, North America is the largest at-home drug of abuse market as in the region the frequency of drug trafficking is increasing. In addition, mounting accessibility of illicit drugs and technological advancement are also up surging growth of the North American at-home drug of abuse market. For instance, according to the Centers for Disease Control and Prevention in 2016, approximately 48.5 million Americans used illicit drugs.

Competitive Insight

UCP Biosciences, Inc. is a leading supplier of drug testing devices providing high quality, completely customizable and innovative products with competitive prices in US and global markets. It offers most comprehensive FDA(510k) approved and CLIA Waived instant Drugs of Abuse products. It is a leading supplier of In Vitro Diagnostics (IVD)—offers top notch Point of Care Testing (POCT) devices ranging from instant urine and saliva drug test devices. It delivers POCT products to a wide range of public and private sector including employment agencies, hospitals, occupational health clinics, distributors, pain management officials, doctor’s offices, resellers and rehabilitation centers.

Assure Tech. (Hangzhou) Co., Ltd. is  a high-tech biotechnology company. The company is specialized in research & development, POCT, production, sell of diagnostic reagents, and biological materials.

Key players in the at-home drug of abuse market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. UCP Biosciences Inc., Assure Tech Co. Ltd., Home Health Ltd., Orient New Life Medical Co. Ltd., Confirm BioSciences, Abbott Laboratories, and Psychemedics Corporation are the key players offering at-home drug of abuse.

Recent Developments by Key Players

The Department of Health and Human Services (HHS) offered funding of USD 58.5 million in contingency management tests for people with stimulant use disorder in California. 

The At Home Drug of Abuse Markett report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • Rapid drug of abuse test kits
  • Breath analyzers
• By Sample
  • Urine
  • Hair
  • Saliva
  • Others

Geographical Segmentation

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research